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ABSTRACT 
Olshan, Arnold Merwin. M. S., University of Rhode Island, August 
196 9. Charactc ri zalion of the Effect of Methylchlo roform Inhalation 
on Hepatic Drug Metabolis1n in the Rat. Major Professor: 
Dr. George C. Fuller. 
Male rats were exposed to inethylchlorofonn (1,1,J-trichloro-
ethane ) vapors (concentration about 2500 PPM) for 24 honrs and t},e 
effects of this treatment on drug responses and hepatic drug 
metabolism studied 24 hours later to dete:nnine the effect of incthyl ·· 
chloroforrn on inducible hepatic cl rug-metaboli zj ng c-nzy;nc s . 
Exposure to methylchloroforrn vapor significantly decrc:~sc>d 
lhe sleeping time of the rat in response to h exobarbilal (120 mti/kg, 
i. p.) and zoxazolamine (80 mg/kg , i. p. ). 
Rat blood and liver n1ethylchloroforn1 content mca2ure:d 
immediately following exposure suggested that the efi"ects of mclhyl -
chloroforin were caused by a systemic actio11 . 
Expc rirncnts v.-ith 9000 x G supernatants indicated tl"'at the 
m .etabolisn1 of hexolnrbital was significantly increased follc,wing 
exposure to nielhylchlorofonn . 
Significantly increased N-cle1ncthyJ2.tion of am ',no p~·:-ine, 
accon1panicd by inc r e<'.sc<l an1ounts of n1icr•)SO~r.c..~ C0-1:0indi;1_; pig;~it"nt 
vi~ 
(cyloch1orne P-450) and rni 1: rosomal NADPJI-cylocliro1ne £ rcduct.ase 
were observed in in vit2·~ cxpcrirncnts using hepatic n1icroson1al 
fractions from rats exposed to.1nethylchlorofonn. The spectral 
properti es of tbe CO-binding pigment in ani.rna l s exposed to n1clbyl-
chl o rofo rrn did not diffc r fron1 controls. 
Pretreatn1ent with actinon1ycin Dor cyclohe;.::in-1iclc prevented 
the decrease in the hexobarbital sleeping tirne in rats exposed l.o 
methylchloroform. Further studies clenrnnslrateC: that Drctr.:.:atrn~nt 
with cycloheximide prevented the increase in inetabolism of an1ino-
pyrine by l'ats exposed lo n1ethylchlorofonn . 
·These observations suggest that the increased drug-n1etab0Jizing 
activity in the exposed rats is due to an accelerated synthc.=>is of th~ 
hepatic clrug-n1elabolizing systern. The inducing -:~ffccts oI rnct}1yl-
chlorofonn appea r lo be related lo tho se produced by µhe nc·1:..2rbi'.~· 1. 
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I. INTRODUCTION 
Huinans may be exposed to srnall concentrations of methyl -
chloroform (l, 1, 1-trichloroethane ) vapors for extend,~d periods of 
time because of its wide use as an brganic solvent and degreaser . 
Knowledge of the possible mechanis1ns of toxic activity of m e lhyl-
chloroform would facili late the d eve lopment of a rnetl10d of detccli.n~ 
early signs of toxicity of this liquid . 
An increase in activity which appears to repre sen t ar1 incn:ased 
concentration of enzyme protein is r e ferred lo as "elu:yrne inducli(111. 1' 
Induction of hepatic drug-n1etabolizing enz.ymes lec.ds to accelcrc.ted 
biotransforrnations of drugs in ~ivo therefore altering the duration 
and inte n s ity of drug actions in co.nirna.ls 2.nd rn;-... n (Conney, 1967 ). 
Studies by Gillette (1963) and Booth a1id Gillette (1962) have 
shown that foreign co1npounds i:i rats may cnhc.nce the activity of 
drug-n-1etabo liz.i,ng enzyn1e s by. at le a~t three cli ffe rent mechar.i s1-:-1s : 
one evoked by anabolic ste1·oids, a secor!d by polycydic hyciro c.:.arhons , 
and a third by phenobarbital. 
ThE:sc three types of inducer:: s ti:nclate varied palh,,·ays of 
drug rn e l a bolism by liver rn:croson1.:::s . This rc·scarch was co1vk<..lc>cl 
to detern-1inr~ if rr1clhylchlorof0rrn is an inducer of hepatic drug-_ 
of the above three types of inducers if the above hypothesis proved 
correct. 
The follo wing para1netcrs of hepatic clrug metabolism were 
investigated: in yivo studies of hcxobarbital and zoxazolamine 
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sleeping time; in vitro rnetabolic studies of zoxazol2.minc hyd:roxylase , 
hexobarbital oxidase, aminopyrine dcmethylase, NADPH cytochrorne c 
reductase, and CO-binding pigment; and studies of liver weigh t an d 
micro so1nal protein. Inhi bi to rs of protein syn the sis (actinom.ycin D 
and cycloheximide) were used as t ools to block the effect of methyl-
chloro.form on hepatic drug metabolis1n and thereby establish that an 
induction process does occur in response to methylchlorofo nn 
exposure . 
II . LITERATURE SURVEY 
Methylchloroform is a chlorinated hydrocarbon . It is a highly 
volatile , colorlc s s liquid with a chloroform type odor (Browning , 196 5) . 
Metabolism 
Methylchloroform is readily absorbed through the lungs 
(Williams, 1959) . Studies by Hake~ al. (1960) sho\ved that methyl-
chloroform was very stable in the body , and while a large part of an 
intravenous dose was excreted unchanged by the lungs , a very small 
part was metabolized to chloroethanol and excreted in the u1·ine as the 
glucuronatc . 
Effects in Anirn.als 
The prirnary toxic effect of methylchlorofo nn is central n··-:rvous 
systcn1 dcpre s sion producing c:>.'.'.le sthesia. Lethal dosage ca'.lSe s central 
nc rvous s ysten1 depres sio~1 re slllting in l·e spi rato ry paralysis (Adarr1s 
et~· , 1959) . At the ar..esth·::'!tic level mcthylchlorofcrm sensitizes 
the h eart 1..o epine phrine causing 2.n idiovenlri.cular rhyth1n (Rennick 
et al., 19·±9). \Vith chroni.c:: expo su re (500 PPM, 7 hours a day, 5 
days a \vcek for 6 months) no e:vidence of in1painncnt of growth or 
healt h v .. as obs erved ii~ rats, rabbits, guinea pigs, and rnonkeys . In 
another study at 2000 PPM for 3 nlcmths, the only anin1al s pecies in 
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which organic injury was observ'3d was the fema le guinea pig. These 
organi c l esions included slight inflammation of the lu ngs and fatty 
changes in t}ie liv e r (Torkelson et al., 19 58 ). The l ethal dose in rats 
by i nhalation is 30, 000 PPM fo r 6 minutes ; 15, 000 PPM for 1 -1/ 2 
hours; and 8000 PPM for 7 hours (Adams~ al., 1950). 
Effects in Man 
Stewart et al. (1 961 ) have reported data obtaine d when seve n 
hum an subj ects we re exposed to constantly increasing concentration s 
of methylchloroform up to 2650 PPM over a period of 15 minutes . 
At 1000 - 1100 PPM and 1 900 -2000 PPM mild eye irritation and throat 
irri tation was noted, re spe ctively, in 6 of the 7 subj ects . At 2650 PPM 
2 subjects were unable to stand and 3 subjects \Vere very light-
h eaded but able to stand . In another test at 9 10 PPM for 35 rniDutcs , 
lighthcadedn~ s s was exp.c ri enced in one of two subjects . These 
subj e ctive and phy sio l ogical responses agreed with the r e sul~s r epcirtcd 
by Torkelson ~t a l. (1 958 ). 
S tcvvart et al. (1 96 1) also rneasured the blood ar:d unne of 
subj ects exposed to methylchloroforrn.. Depending on length of 
exposure an'l concentration of methylchloroforn1, blood s2.rnples ccin -
tained up to 10 PPM and urine sarnp les up to 2 PPM at the tcr1nin ;:;tio n 
of exposure . Thirty minutes after ·2xposure only t race aroounts 
( (1. 0 PPM) of ID·'.:! thylchloroforrn could be found in lh '2! blood or 
urine . 
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Previous investigations (Lal and Shah, 1968 ) have suggested 
a possible role of mcthylchloroform as an inducer of hepatic drug-
metabolizing enzymes in rodents . 
O xidative Dru_g_~etab~.!_is~ 
Early investigations have established that the enz.ymati c. 
metabolism of foreign compounds is carried out by enzymes located 
in the inicrosomal fraction of the liver and are dependent on the 
generation of NADPH by the soluble fraction. Although the mechanism 
of drug oxidation by inicroso1nes is not yet cJear, M as on (1957) pro-
posed that the oxidative reaction is coupled to a microsom.a l electron 
transport system. ope rating between NADPH and oxygen. Siekevitz 
(1965) has r evi ewe d the n1icrosomal electron transport systems an d 
suggests that the -following pathway may be operative for the passage 
of electrons from NADPH to oxygen: 
NADPH Fiavoprotei n ~, 
I 
' 
' Exogenous 
c ytoch ro1nc C 
? ----, cytochro1ne P-450 
~\. 
drug ·oxidized drug 
Cytochrorrc P-450 is the microson-1al hernoprotcin that is believed to 
function as the oxygen-activating en z.yrne and te rnii nal oxidase for 
hydroxylaling a nu1nbcr of drugs and steroids . Evidence for the 
existence of this cytochrome '.V<tS first presented by Kli.ngcnbc rg (1958) 
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and Garfinke l (1 948 ) and has since been extensively studied by Omura and 
Sato (1964). The he1noprotein can be characterizc<l by its reactivity 
with carbon inonoxide and ethyl. i socyanide . The pigment has been 
termed cytochrome P-450 because in the reduced form reaction with 
carbon monoxide exhibits an absorption inaximum at 450 mp . 
In 1965 Cooper et al. presented evidence for the participation 
of cytochrome P-450 in NADPH dependent rnic rosomal systems 
respon sible for the inetabolism of many drugs . They showed that the 
liver micro sornal oxidation of codeine, 4-rnononi.ethylarnino-
antipyrine, and acetanilide was inhibited by carbon rnonoxide and that 
this inhibition could be reversed by monochromatic light at 450 rnµ or 
by oxygen . Kuntzman ~ al. (19 6 8 ) irnplicated cytocb rome P-4 50 as 
the terminal oxidase for steroid hydroxylation of te sto ste rone by liver 
enzymes with his findings that the hydroxylation of te stos terone by 
li vc r mic rosoni.e s could be in hi.bi ted by carbon monoxide and that 
this inhibition was reversed by rnonochromatic light. 
At the pre sent ti1ne the re is a question as to whether li vc r 
rnicrosoni.cs contain 0ne or rnore different heinoprote ins that function 
in hyd roxyla.tion reactions. Remme r and Merker (196 5) and Sladek 
and Manncring (1966) have sho,vn that phenobarbi tal or 3-methyl-
cholanthrenc increases the conc e ntration of cytochro1ne P-450 . 
Alvares ~~~ l. (1967) and Kuntzrnan et al. (1968) have shown that in 
3-mclhylcholanthrcne treated rats, carb0n rnonoxide interacts with the 
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reduced microso1nal hemoprotein to give an absorption maxirnuin at 
448 mp instead of an absorption maximum at 450 mp which i.s seen 
in the untreated and phenobarbital treated rats. Imai and Sato (1966) 
also presented evidence for two forrns of cytochrome P-450 based 
on different spectral properti es seen with phenobarbital or 
3-me thylcholanthr e ne tr eate d rats when ethyl isocyanide was used as 
the ligand for the reduced h ernopro t ein. It is feasible that 3-methyl-
cholanthrene or its metabolite binds to the hemoproiein, and this 
bound h emoprote in pos sesses spe ctral properties different from 
untreated or phenobarbital treated rats. Other possibili.ties are the 
induc e d synthes is of a spectrally different hemoprotein or in conversion 
of one form of he mo prote in to anolhe r fo rn1 in the presence of the 
inducer. Kuntzman et al. (1 968 ) and Alvares et al. (19 67) have shown 
that pretreahnent of rats with e thionine or -actinomycin D prevente d 
the peak s hift to 448 1np caused by 3 -methylcholanthrene . In vivo 
administrati on of 3 -methylch.alanthr ene to" anirnals 2 hours prior to 
sacrifjce or in '.':'.:_i tr~ addition of 3-m ethylcholanlhr ene to microsomal 
suspension did not cause any spectral changes (Kuntzman~ c.l., 196 8). 
These r esults sugges t the s yn thesis of a new h en10protein but the t 1·ue 
solution will have to \Va.it for solubili za lion and purification of the 
hen1opro tein(s ) found ir1 norrnal, phenobarbital and 3-mcthylcholanlhrE.;ne 
anirnals. 
Jick and Shuster (J.966 ), Ern s ter and Orrcnius (1 965 ) and RcmnlCr 
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and Merker (1965 ) have reported that treatment with phenobarbital 
increases liver microsomal NADPH cytochrome.£ reductase levels 
in the rat al1nost two fold . Von Der Decker and Hultin (1960) and 
Kato and Takayanaghi (1966) demonstrated that the administration of 
3-methylcholanthrene had no effect on NADPH cytochrome.£ reductase . 
Thus , NADPH-cytochrome .£ reductase and P-450 are established as 
compone nts of the oxidative drug -n1etabolizing syste1n of liver 
micros01nes and the activity of same should be evaluated in the presence 
of suspected induction of the drug-mctabolj zing enzymes . 
At the present time at least 200 chemicals have been identifjecl 
as induce rs of drug-metabolizing enzymes (Conney, 1967) . In studic s 
where two different types of inducers (i . e., phenobaTbital and 
3 -methylcholanthrene) we re used together, liver microson1e s we re 
more active than studies where each was used alone or where two 
drugs of a similar type (i . e ., 3-methylcholanthrene and 3, 4-
benzpyrene } were u sed togethe r (Gillette, 1963) . A similar in vitro 
study using ACTH and 3, 4-bcnzpyrene (with zoxazolan1ine as the 
substrate) and phenobarbital and inethyl testosterone (with nl.ono-
methyl-tJ -anljno antipyrine as the substrate.:) showed a sti1nulalion 
of drug rn etabolism. more t han n1axin1u1n doses of 3, 4-benzpyrene or 
phenobarbita l could proch:ce. This indicated a third possjb1e ty~c of 
inducer, the an abo lic steroids. 
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These three general types of inducers stimulate varied pathways 
of metabolism by liver mic rosomes. The re is a large overlap in the 
types of reactions and in specific pathways induce<l with individual 
drugs or chemicals. In general, 3-methylcholanthrene sti1nulates a 
more limited group of reactions than phenobarbital or the anaboli c 
steroids . 
Conney et al. (1960) and Kato and Takayanaghi (1966) have 
shown that 3-methylcholanthrene increases the metabolism of 
zoxazolamine in rats but has no effect on the in vitro rnetabolism of 
hexobarbital or aminopyrine, while phen obarbital significantly incrc;;ased 
the metabolisn~ of all three drugs. Anabolic steroids increase the 
metabolisn~ of h exobarbital (Booth and Gillette, 1962); stimulate the 
N-dc methylation of aminopyrine (Kato and Takayanaghi, 1966); but do 
not significantly alter zoxa zolarnine hydroxylase activity (Gillette, 
196 3; Kato and Takayanaghi, 1966). 
Hexo barbital slec ping time is often used as an accurate indicator 
of inicrosom.al drug metabolism . The duration of hexobarbital hypnosis 
in rats is si.gnificai1tly shortened by treatment with phenobarbital 
(C onney~_!. al., 19 6 0) :rnd anabolic steroids (Booth and Gillette, 1962) 
but is not alter c:d by 3 --rnctl:yi cho lanlhrene type drugs (Connf:'y !'._~ ?-l·, 
1960 ). The duration of :z.oxazolarninr? paralysis is s ignificantly l"E:duc:r::d 
by trcalrnent of cats \\'itl1 ph~' 11obarbilal or 3-methylcholanthrcne 
(Conney~~·, 1960), or in mice by a : -iabolic steroid s (Novick~~:, 196 0) . 
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The time required for the various types of induce rs to produce 
an effect differs . While phenobarbital produces stimulatory effects 
on enzyme activity in 1-4 days (Conney et al., 1960), polycyclic 
hydrocarbons take only 3 lo 6 hours with maximum effects observed 
in 24 hours (Conney et al., 1956). Methyl testosterone induction is 
not apparent except after prolonged administration {weeks) (Booth and 
Gilette, 1962). 
Phenobarbital, polycyclic hydrocarbons, and anabolic steroids 
may increase the l evels of liver microsomal enzyrnes by stabilizing 
these enzymes as well as by accelerating the rate of Eynthesis. 
Kinetic s tu dies with mouse tis sue have shown that phenobarbital 
causes an increase in liver NADPH-cytochrome !'.:. reductase levels by 
increasing the rate of synthesis and by decreasing the rate of breakdown 
(Rubin~~- ·, 1964). 
While phenobarbital causes a 20 -40% increase in rni c ro son1al 
pro"tcin per gra:::n of liver (Conney~ al., 1960), 3-methylcholc:,nthrcne 
(Conney~ al. , 1960) and the anabolic sle raids (Booth and Gille tte, 
1962 ) cau se no increase in microsoinal protein per gram of liv e r. 
Pheno barbital and 3 -rnethylcholanthrene ad ministered to rats for 
2 to 3 days increased tl1e liver to body weight ratios 20 to 30% but 
prolonger! treatment v.rith anabolic s teroids did Pot signif ica ntly 
cha.nge this ratio. 
Electron microscopic exa1nination of si·nooth surfaced 
l l 
endoplasrnic reticulum is a useful index of drug induced changes 
in li vc r n1.ic rosomal enzyn1e levels. Phcnobarbi tal causes pro life ra -
tion of smooth surfaced endoplasn1.ic reticulun1. in liver cells but has 
little effect on rough surfaced endoplasmic reticulum, while 
3 -methylcholanthrene has little or no effect on smooth surface d 
endoplasmic reticulum (Rc!nmer and Merker, 1965). 
Inhibitors of Protein Synthi::_::_~~ 
The induction of drug-metabolizing enzyme activity by phc no -
barbital or 3 -methylcholanthrene is blocked by ethionine (Conney~ ~l_. , 
195 6; Conney ~al. , 1960); puromycin (G e l boin and Blai:::kburn, 1964; 
Orrenius et al. , 1965); ar.d actinomycin D (Gelboin and Blackburn, 1964; 
Orr enius ~ al. , 1965). 
These inhibitors blo_ck protejn synthesis by various mechanisn1s. 
Ethionine appears to block protein synthesis by decreasing the ATP 
levels in the liver (Villa-Trevino~ al., 1963); purornycin has been 
reported to block the transfer of soluble RNA-bound amino acid into 
microsomal protein (Yarrnolinsky and De La Haba, 1956); and actino -
mycin D binds to DNA, and therefore may act by blocking the DNA 
directed synthesis of nuclear RNA required for protein synthesis 
(.R eich et~., 1961) . Ho weve r, R eic h (1 964 ) has also reported that 
actinornyci n D inhibits strand separation of h e lical DNA and suppresses 
DNA polymerase activity. Thus it is clear th at actinornycin D 
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activity is exerted at the level of the nucleus. 
Cyclohexim.ide, another known inhibitor of protein synthesis, 
is reported to act on extranuclcar co1nponcnts . Korner (1966) reported 
that the liver ribosomes of :rats given cycloheximide by intra-
peritoneal injection incorporate less amino acids into protein than 
ri boson1e s from control rat liver. Their experiments showed that 
. 14 
cycloheximide treated animals incorporated 95% less 1-leucrne - C 
into ribosomal proteins. Studies by Harris et al. (1968) show that 
a single dose of cycloheximide in rats inhibited the incorporation of 
uridine- 3H into nucleolar RNA with maximum inhibition at 24 hours. 
III. EXPERIMENTAL 
Animals 
Male Sprague -Dawley der ived rats obtained from Charles 
River Breeding Laboratories (Wilmington, Mass .) , weighing 
between 60 2.nd 100 gin . we re used throughout the course of this 
study . The animals were maintained on commercial laboratory chow 
and water ad libitum. Rats were used not earlier than four days 
after being received from the supplier via commercial shippers 
or were used the following day when personally picked up at the 
source of supply. Rats we re n1aintaine d in a room with controlled 
tempc rature and alternating 12 hour periods of li ght and darkness . 
All drugs were adrninistered via the intraperitoneal route . 
Mate rials 
Analytical reaGent grade chemicals O·r equivalent were used 
throughout this study. Co -factors (NADP, NADPH, glucose -6 -
phosphate, cytochrome£• and glucosc-6-phosphate dehydrogeP.ase) 
and crystal.line bovine scrum albun1in were purchased from 
Calbioche1n. The drugs used in this investigation were obtained 
£ro1n their respective m.anufacturers. The toluene used was the 25% 
fraction th a t re1nained after distillation. 
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Inhalation Chamber 
The chambe r consisted of a flat bottom cylindrical glass jar 
(12 11 x 18 11 ) placed horizontally on a wooden platform . The open end 
of the jar was closed by a wooden frame with a cork ring . The 
wooden frame was fitted with a removable circular wooden hatch 
(9/2" diameter) for the introduction of animals and a 4-hole rubber 
stopper (2 11 diameter) . Two copper tubes reaching the end of the jar, 
a copper tube r eaching only the front of the jar, and a th e rmometer 
were inserted through these holes . 
Methylchloroform Exposure Protocol 
The animals we re plac ed into the inhalation cham.ber onto a 
perforated platform. The exposure atmosphere was forn~ed by the 
passing of air at a rate of 0 . 2 liters/minute through a gas drying 
bottle containing methylchloroform and subsequent dilution with air 
at a flow rate of 10 liters air/n1inute . Equilib riun1 of the chamber 
atmosphere was achieved by introducing the air mixture through the 
long copper tubes described above with venting via the short copper 
tube. The desired flow rates were n1aintained by the use of flow meters 
(Hoke, Inc., Style 993) . The animals were a.llo we d fr ee access to food 
and water for the entire p eriod of exposure . At the end of the exposure, 
they were transferred to battery cages until used. The exposure pro-
tocol used for all studies relating to drug n1etab0Esm was a single 
24 hour exposure with observations n1ade 24 hours after the terinination 
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o f exposure . Those animals used for U1e a~; sc..y of liver and b l ood 
were sacrificed irnrnediate l y upon removal fl'om the cham.bcr . 
An Aerograph Autoprep A-700 Gas Chromatograph (Vari.ens, 
Inc . , California) equipped \\rith a t hermal conduci-ivit )' detector with 
a Speeclornax X recorder ··.vas usc:d to lne:asu.rc the: conccntral.ion o f 
methylchloroform in the exposure chambc:r . k1 18% Hi Eff-3J3P on 
60/80 Chro1nosorb w A- 10 colmnn (m.:ope1,tyl succ-i.n ::~tc on acid 
\vashcd chrornosorb) obtained from. Applied Sdcnce: (Pbilacklp!1ia., r.:.<:1. ) 
was used . The column tcrnperature was set to about 73°C, injector 
0 0 
t en1perature t o auout 130 c, and detector temperature t:-i abo 1 it 83 c . 
The filament was set at 200 ina . Helium. with a gas flow of 60 in} /n1innte 
was used as the- carrier gas . For the standard, 2 pl of pure rnethyl-
chlorc•fonn was injcc1f-: d i;1to the inslrun1cnt at an attenurtti.u:"! ':'•f J 6 . 
For the sar;1 p1':~, . 20 lnl of cha1nber air was injected into thr:: ch<,1;1bcr 
at ;:in ci.Uerw:~ tio11 of 2. The areas i..rn c1er the standard an<l s<.1.rnple peak:-
were calculated and i-'pn:.. \•;ere clcterrn inecl using the equivalent 
1 mg/liter= 1S3 pprn (Bro w1,:ng, Vi 6 5) . 
extracteci \\'ith 2 volun-1es of toluc·n C'. J\.n A t.: rograph Hy Fi Moc'.cl 
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Electron Capture Detector with a tritium source and a Honeywell 
Electronic 118 Recorder was used. A 20% GP 29A, ABS 60 /70 column 
(20% carbowax 20M terminated with terephthalic acid groups on acid, 
alcohol, base washed diatomaceous earth) obtained fro1n Anal abs , Inc. 
(Hamden, Conn.) was used. Nitrogen was used as the carrier gas 
at a flow that permitted maxin~um separation. Since the determination 
was not linear, the following n1ethylchloroform concentrations \.Ve re 
used as standards: 0. 1, 0. 5, 1. 0, 2. 0, 4. 0, 5. 0, 6. 0, 8. 0, 10. 0 ppn1 
and a standard curve drawn. Two pl of all samples and standards 
were injected into the instrument. Peak heights were measured and 
the sample concentrations determined by extrapolation frorn a standard 
curve. 
Determination of Sleeping Time 
Duration of pharmacologic response of the depressant drugs 
employed in this study was measured using sleeping ti1ne as an end-
point. Animals were weighed,_ marked, and placed into cages i1n-· 
mediately ?rior to use. Hexo barbital solutions we re prepared in 
distilled water with a s1nall amount of lN NaOH in a concentration 
which permitted the adn1inistration of 10 ml/kg. Zoxazol2.n~ine was 
prepar e d as a suspension in 0. 5% methylcellulose in a conc entration 
which also permitted the administration of 10 ml/kg. Slee ping time 
was take n as the length of time b etween the loss and regaining of the 
righting reflex. 
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Collection of Biological Samples 
Blood. Methylchloroform-:reated animals were sacrificed 
immediately upon removal from the exposure chamber (exposed 
24 hrs . at atmospheric concentration of about 2500 ppm mcthyl-
chloroform) by decapitation and the free-flowing blood collected in 
a beaker containing a few drops of 33% sodium citrate solution. The 
blood was frozen until assayed . Blood from control rats was collected 
in the same manner . 
Liver . Immediately after decapitation and collection of blood 
(above), the livers were removed, homogenized in 1 volume of 0. 1 M 
phosphate buffer (pH- 7 . 4) and extracted with 2 volumes of toluene . 
These samples were stored in the freezer until assayed for methyl-
chlorofo rm. Control experiments established that no me~hylchlo!"ofo nn 
was lost during storage. 
Preparati o n of Liver Microsomes 
Animals were sacrificed by cervical ~islocation, the abdomen 
opened and the livers p e rfused with 1.15% KCl solution via the hepatic 
portal vein . The livers were quickly excised, weighed, minced with 
scissors, a.nd homogenized for 60 seconds in 2 volmnes of ice cold 
0.1 M phosphate buffer (pH 7. 4) in a motor driven coaxi a l homogenizer. 
The homogenates were centrifuged for 30 1ninutcs al 0° and 10, 000 rpn1 
(9000 x Gave . ) in an Internationa l model B-60 preparative ultracentri-
fuge (r o tor #874). The supernate was decanted and centrifuged at 
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30, 000 rpm (78, 000 x G ave.) for one hour to obtain the microsomal 
fraction. The m .icrosomal pellet was washed and resuspended in 
cold 0. 1 M phosphate buffer (pH 7. 4) in a volume equivalent to that 
of the original liver. Aliquots of the microsomal suspension and 
78, 000 x G supernatants we re frozen and stored at -10° C until 
assayed. 
Preparation of 9000 x G Supernatants 
Rats were sacrificed by cervical dislocation, and the livers 
homog enized as described above . The 9000 x G supernate fraction 
was taken after centrifugation at o0 c at 10, 000 rpm in an Inter -
national #874 rotor for 30 minutes and stored at -10°C until assayed. 
Determination of Protein 
9000 x G supernatant and microsomal protein were estimated 
by the method described by Lowry~ al., (1951). About 165 mg· of 
liver equivalent for the 9000 x G supernatants and about 333 rng of 
liver equivalent for microsomes were plac ed into 50 ml c ent rifuge 
tubes containing enough 0. 5 N NaOH for a final volume of 10. 0 ml. 
The tubes were placed i nto a water bath and heated at 75°C until 
dissoluti on was complete. Standard solutions of fr eshly prepared 
crystalline bovine serum albmnin in 0. 5 N NaOH and a blank consisting 
of 0. 5 N NaOH soluti c, n were carried through the entire procedure . 
When the ti ssue was complete ly di sso l ved , an 0. 2 rn.l (9000 x G super-
natants) or 0. 4 ml (n1icros ornes ) aliquot \\·as \vithdrawn and placed into 
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a second tube containing 1. 0 ml o f 0. 5 N NaOH. Five ml of reagent A 
(1. 0 ml of 2. 7% potassium tartra te ~ ~ HzO, 1. 0 ml of 1. 0% CuS 0 4 · 5Hz0, 
and 100 ml of 2 . 0% NazC0 3 ) was added and the tubes mixed and allowe d 
to stand at room temperature for 20 minutes . Then 0. 5 nu of reagent 
B (cornmercial folin phenol reagent diluted to 1 N with distilled water ) 
was added and the tubes mixed and allowed to stand at roorn tempera -
ture for 40 m.inutes b e fore being read in a Beckinan DB-G grating 
spectrophotometer at 50 0 mµ versus an 0. 5 N NaOH blank. 
Determination of !E. ~~ N -demethylation of Aminopyrine 
The method of McMahon and Easton (1962) was employed to 
measure the formaldehyde form.ed during the in vitro N-demethylation 
of aminopyrine by liver fractions . A typical incubation mix tu re con -
tained 1. 0 ml of 9000 x G supernatant or 1. 0 ml of 78, 000.x G super -
natant and 1. 0 ml of microsomes (about 333 mg of live r equivalent), 
10 pMoles of aminopyrine (substrate), 45 µMoles of semicarbazide , 
30 µMoles of glucose --6-phosphate, 4 µMoles. of NADP, 50 pMole s of 
MgClz · 6Hz0, 50 pMoles oi nicotinamide, and 300 pMoles of 0 . 1 M 
phosphate buffer (pH 7 . 4) in a total volume of 5 . 0 ml in 25 ml erlen-
myer flasks . Parall e l incubation flasks containing 1. 32 µMoles of 
forinal dehyde (sl2.nclard) in pl::ice of substrate and distilled \vater 
(blank) in place of subst rate were carried through the entire procedure . 
Tbc fla sLs \\·ere incubated in a Dubnoff shaker at 3 7° C uncle r air 
for 30 minutes . At the end of the in cu b ation p eriod , the flask conte nts 
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were poured into centrifuge h1bes . Four ml of 10% zinc chloride 
(prepared with COz-free water) were added and the tubes mixed . Two 
ml of a saturated solution of barium hydroxide were added and the 
sarn.ples again mixed . The tubes were centrifuged for about 10 minutes 
and 5. 0 ml aliquots of the clear supernate s we re transferred to clean 
centrifuge tubes containing 2. 0 ml of double strength Nash reagent 
(0. 04 M acetylacetone in 0 . 4 M ammonium acetate -0.1 M acetic acid). 
the contents we re mixed and the tubes heated in a water bath at 60°C 
for 30 n1inutes . The colors were read against the blank using a 
Beckman DB-G grc..ting spectrophotometer at 410 mµ. 
Determination of In Vitro Metabolism of Hexobarbital 
The method described by Cooper and Brodie (1953) was used 
to measure the disappearance of hexobarbital from. incubation medi.a. 
The basic incubation mixture and cop.ditions as previously described 
1 
were used with sernicarbazide o;-i1itted and hexobarbital as the 
substrate . After incubation for 30 rninutcs at 37°C in a Dubnoff 
shaker, t11e iL:.._sk \·olmne s \.ve re transfer red to 50 ml centrifuge 
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tubes containing l. 0 gm. NaCl and 1. 5 ml phosphate buffer (pH-5. 5) . 
1 A standard solution \Vas prepared by dis solving 91. 5 rng of hexo -
barbital in 200 ml of ciistilled water with 1. 2 ml of 1 N N aOH. Incuba-
tion mi::-: ture ust!d 1. 0 rnl (1. 94 µMoles He xobarbital Na) of the stand a rd 
soluti o n in total volun1e of 4. 0 n11. 
2Prepar c d by adding 8. 5 ml oi 0. 119 Gm Na 2HP04 1!1 10. 0 ml to 191. 5 ml 
of 1. 82.0 Gn1 I~HzP04 in 200 rnl 2.nd washed with petrol e un1 ether con-
taining L 5% isoan1yl aJ c o hol. 
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Thirty ml of washed p e troleum ether containing 1. 5% isoamyl alcohol 
was added and the mixtures were shaken for 45 minutes and centri-
fuged for 10 minutes. Twenty ml aliquots of the solvent phase were 
transferred to clean tubes and shaken w ith 10. 0 ml of phosphate 
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buffer (pH-11) for 10 minutes. The tubes were centrifuged and the 
petroleum ether was removed . The optical densities of the unmetabo-
lized h exobarbital (aqueous phase) were d e t ermined at 245 mp. on a 
Beckn1an DB -G grating spectrophotometer . Two parallel incubation 
fl2.sks were carried through the procedu re , one containing 100 µgm 
hexobarbital sodium (standard) with boiled tissue and the other con-
taining tissue but no hexobarbital sodium to serve as the blank. 
Determination of In_ Yit.r.o Metabolis1n of Zoxazolamine 
The i._1'} vitro hydroxylation of zoxazolamine was n1ea su red by 
the method of Juchau et al. , (1965) . The basic incubation mixture and 
conditions as previously described were used with semicarbazi<le 
3 
omitted and zoxazola1nine as the substrate . Afte r incubation, 2. 0 rnl 
1 Solv ents were purified oy washing with 1 N NaOH, 1 N HCl and two 
washings ·with distilled •..vatc r . A technical grade of petroleum ether 
was adequate but a reagent grade of isoa1nyl alcohol was needed. 
2 Pre par ed by adding 8 . 5 Grn of NaOH to 500 . 0 rnl of 0. 8 M Na2HP04 
anhydrou s . 
3 A standard solution 'Nas prepared by dissolving 50. 0 mg of zoxazol-
arnine in 50 ml of 0.1 M phosphate bu ffe r (pH 7. 1J- ) with a small arnom1t 
of 0.1 N I-TCl. Incubation mixtu;e used 0. 5 ml (3. 0 µMoles zoxazol-
atni nc) of tl:c st<;, ncla rd solul i.on in a total volun1c of 5 . 0 nil. 
of the incubate was shaken with 25. 0 rn.l of h eptane containing 1. 5% 
isoamyl alcohol and 0. 5 ml of 1. 0 N NaOH for 30 minutes and 
centrifuged for 5 minutes . Twenty ml of the heptane layer was 
pipetted into a second centrifuge h1be containing 7. 0 ml acetate 
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buffer {pH 5. 6), shaken for 5 minutes, and centrifuged for 5 minute s. 
Fifteen ml of the h e ptane layer was shaken for 15 minutes with 7 . 0 ml 
of 0.1 N HCl and centrifuged for 15 minutes . The optical density of 
the aqueous phase was read at 278 mp against a 0.1 N HCl blank on 
a Beckma.r, DB-G grating spectrophotometer . The arnount of 
zoxazolan:1ine metabolized was calculated as the difference in the 
amounts extracted from zero time (unincubated) and the incubated 
flasks. 
Dete nnination of Microsomal NADPH-Cytochron1e ~ Reductase 
Activity 
The system ernployed for the estimation of NADPH-cytochrorn.e c 
reduct ase was a n1odification of that described by Ernster e t al., (196?..) 
and Dallner (1963) . This assay is based on the detern1ination of the 
rate of reduction o f cytochrome£ through measure1nent of thE: 
absorbanc:e increase of the reduced cytochrome at 550 mµ . 
Microson1al suspension containing 0. 5 mg /ml of protein 1n 
0.05 M phosp:!--iate buffer (pH 7.4) were employed for this assay . The 
assay syster:n contained 0. 67 ;u.Molc:s NADPH, 0. 33 µMoles cyto-
chrome£• and 0. 99 pMoks KCN in 0. 05 M phosphate buffer (pH 7. 4 ) 
23 
rn a total volume of 3. 0 ml. These r eagents we re pl ace d in both the 
reference and sample cuvettes of a Beckman DB -G grating spectro-
photometer equipped with a thermostatic cell compartment held at 
37°C a n d a B e c kman linea r-log potentiornetric recorder (Model 1005). 
A 0 .1 ml aliquot (0. 0 5 mg of protein) of microsomal suspension was 
introduced into the sample cuvette and mixed. The linear change 
in absorbance over a 5 minute p eriod at 550 mp was recorded. An 
extinction coefficient of 18. 5 x 10 3 at 550 mp for reduced minus 
oxidized cytochrome£ (Margoliash, 1954) wa s used in the calculations. 
The results were expressed as pMolcs of cytochrome£ reduced per 
minutes per mg n1icrosomal protein . 
Determination of CO-Binding_!2gment (P-450) 
The system employed for the estimation of CO-binding pigment 
(cytochro~e P -45 0) was_ similar to that described by Dallne r (1963). 
The assay was conducted in a Cary Model 15 recording spe ct rophoto-
meter. 
To 6 . 0 ml microsomal suspension (pr epared in 0. 0 5 M 
phosphate buffer (pH 7. 4 ) to contain 1 mg protein/ml) a few mg of 
Na dithionc..te were added to reduce the rnicrosomal pigments. Three 
ml of n1icros o rnal suspension were placed into each of 2 cuvett.es and 
the spectrum recorcled from 500 to 400 n:1p . Carbon ino noxide was 
bubbled through the sa.mple cuvette for a period of 1 minute . The 
speclrun1 was again scanne d fr o rn. 500 to 400 m.µ and lhe absorbance 
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recorded. The absorbancc at 500 mp and at 450 mµ was taken from 
the recording and the content of the CO-binding pigment was expresse d 
as the difference in absorbance between 450 and 500 mp. per rng of 
micro so1nal protein. 
Statistical Methods 
Student's t test (Dixon and Massey, 1957) was used to test 
for differences between means throughout this investigation. The 
formula en1ployed is as follo'ws: 
where; 
t = 
2 
s p 
xl -
2 
Sp 
= 
Xz 
(nl + n2) 
nl nz 
2 
-1) s 
l 
(n 
2 
-2 
2 
-1) s 
2 
X1 = control mean, X2 = treatment mean 
n 1 = c ontrol sample size, n 2 = treatlnent group sarnple 
size 
2 2 
s 1 =- control variance, s 2 = treatnwnt variance 
Calculationf; we re p~ rfo rrnt:!d on an IBl'A. 360 cornpute r. The program 
was written in Fortran four language. The de gre8 s of freeclom. we re 
taken as n 1 + n 2 -2. The l eve ls of p \ ;:ere taken from appendix 5 
(Di xon and Massey, 195 "/). 
IV. RESULTS 
In all expe rirnents rats were exposed to a mcthylchloroform 
atmosphere (about 2500 ppm) for 24 hours . 
Methylchloroform Concentration in the Exposure Chamber. 
The concentration of methylchloroform versus the two flow meters 
was deternlined several times throughout the investigation. The flow 
rates used for all experiments (0. 2 liters/minute diluted with 
10 liters air/minute) corresponded to a chamber atmosphere content 
of about 2500 ppm. 
Methylchloroform Content of Rat Blood and Liver Following 
24 Hour Exposure . Methylchloroforn1 was found to be highly con-
centr ated in the liver (12 7 ppm) in contrast to the blood (12. 5 ppm) of 
rats exposed to the methylchloroforrn vapor (about 2500 pprn) for 24 
hours (Table 1). Control experiments established that no methyl-
chloroforrn was lo st from blood s an1ple s collected and stored in a 
fre ezer before extraction with toluene . A pe_ak corresponding to 
me thylchlorofonn was observed in control samples although these 
anin-ials had no known exposure to n1ethylchloroforn1 . This peak 
corresponds to instrurnent sensitivity . 
All of the f ollowing data were obtai11ed 24 hours a f te r tern1ino.tion 
of a 24 hour period of exposure to the methylchloroforin atrnospl:erc . 
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TABLE 1 
ANALYSIS OF METHYLCHLOROFORM IN THE BLOOD AND LIVER 
OF MALE RATS 
pg/gml mµMolcs/gm 
Liver 
Controls (3) <. 0. 1 <.. 0. 7 
Treated 2 (3) 127.3~8.7 3 954.3 ~ 65. 1 
Blood 
pg/ml mpMoles/gm 
Controls (7) <. 0. 1 < o. 7 
Treated (8) + 12.5 - 2.3 93. 7 ~ · 17. 2 
1 Ug/gm were determined by gas chromatography using an Aero -
graph Hi. Fi Chromatograph Model 600- D.. 
2 Treated ani1nals exposed to atmospheric concentrations of about 
2500 ppm methylchloroform for 24 hours. 
3 Results are expressed as mean values + standard error . 
Number of sa!nples is in parentheses. 
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Effect of Methylchloroform on Hcxobarbital Sleeping Time and Hexo-
barbital Oxiclase 
Hexobarbital sleeping time was significantly (p (0. 001) decreased 
(70%) in rats exposed to methylchloroform vapors (Table 2A). In 
other experiments, decreases ranging from 45-80% were observed. 
Significant (p (0. 001) increases of 30% in hexobarbital oxidase were 
observed in hepatic 9000 x G supernate of rats exposed to methyl-
chloroform (Table 2B). These results are in agreement with experi-
ments performed in mice (Lal and Shah, 1968). 
Effect of Mcthylchloroform on Zoxazolami.ne Sleeping Time and 
Zoxazolami.ne Hydroxylase Activity 
Zoxazolamine sleeping time was significantly (p ( 0 . 01) decreased 
by 55 - 60% in rats exposed to methylchloroform (Table 3A) . This 
was accon1panied by a 20% increase (p~O. OS) in in vitro- microsomal 
--- -
zoxazolamine hydroxylase activity (Table 3B). 
Effects of Methylchlo roforrn on Several Hepa.tic Microsomal Para -
The liver/body weight ratio was significantly (p<:O . 05) increased 
by 29% . The trend in the experime nts was for an increase of 20 - 30% 
in the ratio, but an incr ea se was de rnon s trated in oaly half the experi-
ments. As far as microso1nal prote in per weight of iiver, this 
ratio never increased. 
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TABLE 2A 
EFFECT OF METHYLCHLOROFORM ON HEXOBARBIT AL SLEEPING 
TIME IN .THE MALE RAT 
Sleeping time~ 
(min. ± S. E.) 
Controls + 90. 8 - 4. 9 
3 Methylchlorofo rm 
1 
2 
3 
~' 
Sleeping time taken as duration of loss of the righting reflex. 
{Hexobarbital Na 120 mg /kg). 
Results are expressed as the mean values obtained from 11 
animals ± standard error. 
Methylchlo'roform animals exposed to atmospheric concentra-
tions of about 2500 ppm methylchloroform for 24 hours. 
P<0.001. 
TABLE 2B 
EFFECT OF METHYLCHLOROFORM ON THE METABOLISM OF HEXO-
BARBITAL IN RAT LIVER 9000 X G SUPERNATANTS 
------------------- -------- --·----
Co'ntrols 
2 Melhylchloroform 
pMoles]gm liver/30 min. '!: S. E. 1 
2. 541 + o. 061 
3. 365 -±: o. 096'~ 
1 Results are expressed as the mean values obtained frorn 10 
ani1nals -± standard error . 
2 l'v1ethylchloroforn1 anirr.2.ls cxpc.secl to atmospheric concentrations 
of about ?.500 ppm rncthylcblorofonn for 24 hours. 
·'-~· P <o. ooi. 
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TABLE 3A 
EFFECT OF METHYLCHLOROFORM EXPOSURE ON ZOXAZOLAMINE 
Expt # 1 
Expt #2 
SLEEPING TIME IN THE MALE RAT 
Sl . . 1 ecp1ng time 
(min. -!: S. E. )2 
Control 
124 -!: 20. 5 (7) 
106 t 17.5 (7) 
56 -!: 6. 8>!' (6) 
42 ! 5. 5':' (7) 
1 Sle e ping time taken as duration of loss of righting reflex. 
(Zoxazolamine 80 mg /kg). 
2 Results are expressed as the mean values -± standard error with 
size in parentheses . 
3 MC :-: methylchloroform ani1nals exposed to abnospheric concen-
trations of about 2500 pp1n methylchloroform for 24 hours. 
J. ~- P <0.01 
TABLE 3B 
EFFECT OF METHYLCHLOROFORM ON ZOXAZOLAMlNE HYDROXY-
Expt # 1 
Expt # 2 
LASE ACTIVITY IN THE MALE RAT 
mµMoles/mg micros omal prote in ./30 min. 
i S. E. 1 
Control 
210 . 9-± 13. 2 
177. 8 -t 2. 7 
MC 2 
256.1!1 4 .4 ... 
2 1 6 . 6 ! 1 2 . s o:: 
1Results are e xpressed cir; fh e me a n values obtai ne d fro1n 5 c:i.n imals 
±standard error. 
2MC :: n1 ethylchlorofo rrn ri.ni n-1als e x p o s e d to a lm.o s ph e ric conc e ntra-
tions of about 2500 p pm me lh y lchlorofo r m for 24 hours. 
'~p ~o . o5 . 
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Further examination of Table 4 indicated the typical significant 
(p (0. 001) increases in CO-binding pigmen t (P-450) and NADPH-
cytochrome £ reductase activity by 40 and 34%, respectively. 
Spectral peaks of P-450 for both control and rnethylchloroform 
treated samples were the same, at. about 451 mp. 
A 62% significant (p (0. 001) increase in demethylation of 
aminopyrine in the same group of rats. was also noted. In other 
experiments 40 - 80% increases (p <.O. 001) rn the metabolism of 
aminopyrine were obs e rved. 
Effects of Cyclo11e x imide on Various Paramete rs 0£ Hepatic Drug 
Metabolism in the Male Rat 
Cycloheximide , an extra-nuclear protein inhibitor, was used to 
prevent the decrease in hexobarbital sleeping time and increase in 
in vitro metabolism. of aminopyr~ne. The data in Table 5 indicat e 
that the significant decreases in hexobarbi.tal sleeping tirne and signi-
ficant increases in de 1nethylation of aminopyrine caused by methyl-
chloroform treatmc!1.t, can be blocked by pretreatment with cyclo -
heximide . 
Data for liver we ight and supernatant protein are also presente d 
in Table 5. The methylchloroforn1 plus cycloheximide group was not 
different fron1. the methylchlo:rofonn plu s saline group as far as 
weight of liver per -...vcight of rat ratios but was significantly decreased 
(P (0. 001) in supernatant protein per gram of liver. 
TABLE 4 
EFFECTS OF METHYLCB 1_,0ROFORM ON SEVERAL HEPATIC MICROSOMAL CONSTITUENT S IN 
Wt. Liver per 
Br,ciy '0/t. ra~io 
(r!:.g /gm ± S . E. ) 1 
THE MALE RAT 
Microsomal 
protein per 
wt. liver ratio 
.J_ 
(mg/gm '... S. E.) 
CO-binding 
Hgment (P - 450) 
(A450 - 500 /mg/ml 
protein ± S. E.) 
NADPrt - cyto -
chrome c re -
ductase (pM/mg 
protein/min "!: 
S. E.) 
Control + 53.4 - 3.9 15.2± 1.2 0 . 053±0 . 003 0. 333 ± 0. 018 
;vrc 3 .;.. + 68 . I - 3. 3 15.4"± 1.0 0 . 074 ± 0. 003 0 . 44 7 ~ 0 . 0 12 
"p" value .(. 0.05 7 0 . 5 <: 0 . 001 < 0.001 
1 Results are expressed as n1ean values from 6 anirnals ± standard error. 
2 HCEO :: forrr.alflehyde . 
3 MC = Methylchloroform animals exposed to atn1ospheric concentrations of about 
2500 ppm methylchloroform for 24 hours . 
Demethylase 
(aminopyrine) 2 (m,uMoles HCHO 
mg protein) t 
S.E. 
176 . 6±5 .5 
286. 5 ± 1 7. s 
<0.0 01 
w 
..... 
TABLE 5 
EFFECTS OF CYCLOHEXIN'llDE ON VARIOUS PARAMETERS IN THE MALE RAT 
Para1ncte r 
Gro~ 
Co!ltrol & saline 
MC 4 & saEne 
Contra~ & cyclo 5 
MC & cyclo 
liver wt/wt 
of rat i a1..io 
{mg/gm live r 
t S . E.) l 
4i.s±o .7 
52.9±0 . 8 
47 . 7±1.8 
50.o±i.1 
9000 x G 
supe rnatar.t 
protein (mg/gm 
. + liver - S. E . ) 
95 . 6 ± 2.4 
.l.. 
104.4 !. 3.5 
+ 88 . 5 - 2. 1 
84 . 8 ± 2. 5 
Hexobarbi tal 
Sleeping Time 2 
(min t S. E.) 
78. 3 ± 7. 7 
.l.. 
14 . 9 .!.. 0 . 9 
121.5±4.1 
87 . 1±9_7 
Amino-
pynne 
Metabolism 
(rnµMo~es 
HCHO /mg 
protein I 
30 min . ± 
S.E . ) 
36 . 8 t 2. 2 
64. 6 ± 7 . 0 
23_5±2 . 2 
24.8 t2 . 6 
1 Results are expressed as mean vali.les of six rats ~ standard error. 
2 Sleeping time Laken as duratio::i. of loss oi righting r~flex. (Hexobarbital Na 120mg/kg.) 
3 :I CI-IO = form.al dchyd.c. 
4 ?viC = mefoylc hlo rofo rm animals exposed to atmuspl:e ri c con.cent rations 
2.500 ppm rncthylchlor0£orm for 24 hours . 
5 Cyclo =- cydohcximide (2. 5 mg/kg) half hour be±:o!"e MC treatment. 
of about 
w 
N 
... 
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Effect of Aclinomycin Don H cxobarbital Slcepin_g_ Tim~-~~ the Ma~R~ 
Treatlnent with actinomycin D (protein ir,hibitor at the nuclear 
level ) at a dose of 40 µg/kg 30 min . b efore n1et.hylchloroform treatment 
and 40 µg/kg 12 hours l ate r did I !O t prevent the signific;"\.nt clecrt:ase in 
hexobarbital sleeping tin1e caused by meLhylchloroform (Ta~Jle 6A}. 
A dose of actinomycin D 80 µ g/kg 30 min. before methyl-
chloroforrn lrealrnent and 40 p g/kg 12 r.o ,ns later caused a. sjg11i ficant 
inhibition (pt:.. 0 . 01) of the methylchJorofo.rm induced d~ crcase in 
h exobarbiial sleeping time (T able 613) . 
TABLE 6A 
EFFECT OF ACTINOMYCIN DON IIEXOBARBITAL SLEEPING 
TIME IN THE MALE RAT 
Gr~~ 
Control 
MC 4 
C 1 &. . 5 ontro acbno 
MC & actino 
1 
______ T ___________ _ 
Sleeping lime 
(rnin.-!: S.E.) 2 
-!: 3 112.5 8.7 (6) 
44. 8 t 6. 0 (6 ) 
111. 5 + 12. 2 (6) 
51.7-±: 8.3(6) 
Sleep)ng tirnc taken as duration of loss of righUng reflex . 
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2 ResultG are expressed as the mean values-!: st<Jnclard error . 
3 Animals pc r group. 
4 MC = n1ethylchlorofo rn-1 ani rnals exposed to atmosphc ric con -
centrations of about 2500 ppn-i methylchloroform for 24 hours. 
5 Actino = actinomycin D 40 µg/kg 30 min. before MC treat-
m e nt and 40 µg/kg 12 hours later. 
TABLE 6B 
EFFECT OF ACTIN01\1YCIN D ON HEXOBARBIT AL SLEEPING 
TIME IN THE MALE RAT 
------·---------------Slce~°ing ;irne 1-
2
------------·-----
(min. -!." S . E.) 
gl.:~~.P 
+ (7)3 con l rol 11 6 5. 7 
MC 4 48 + 2. 1 (8) 
Con t r ol &. actino 5 118 + 4 .2 (8) 
MC & aclino 72 t 7. 1 (10) 
Sleeping 1.irrie taken as c~uration oi loss cf ri.ghtin ~ n:flcx- . 
2 Results are cxprc"!ssed ac, th-=. ni.can V2.1u es t stancl<inl C'rror. 
3 P.nirnals per group. 
4 MC:.. n1cthylchloro.:-orrn an}1nals e:-cposecl lo ati~usph~r!c ct~J~ ­
ccntrabons of about 2500 ppm 1ncthylchloroic.rin for 2-1 h .. :.:r~~ . 
5 Actino = act.inon1ycin D 80 uglkg 30 mi ·1. before MC treat-
ment and 40 ,ug /kg 12 hours lalc r. 
V. DISCUSSION 
This investigation indica.ted that hepatic drug-metabolizing 
enzyrnes in rats are stimulated by exposure to methylchlo:::oform 
vapor. Methylchlorofonn was detected and measured in the liver and 
blood of exposed rats thus providing justification for a hypothesis 
that methylchlo roform exerts a systemic effect. Studies by Stewart 
et al. (1961) in humans confirmed that methylchloroform blood concen-
trations are related to exposure . 
Exposure to m ethyl chloroform vapor significantly shortened 
hexobarbital and zoxazolamine sleeping time as do inducers of the 
phenobarbital type (Conney~ al., 1960) and anabolic steroid type 
(Booth and Gillette, 1962; Novick~ al., 1966). Induc er s of the 
3-methylch0lanthre ne type only reduce zoxazolamine sleeping tin1e 
(Conney~ a~. , 1960 ). 
In vitro paramete rs of drug metabolism (hexoba rbit.al oxidase , 
aminopyrinc N-den1ethy l ase , and zoxazol an1ine hydroxylase) 'vvcre 
significantly increased by n1et.hylchJ orofo nn exposure. Phe no b arbital 
has been reported to cause increases in the sarne p ara1neter s (Conney 
et al., 1960; Kato and Takayanaghi, 1966). Anabolic stc roids 
significantly increase thel2! ~iJ:I.<.? metabolism of hexobarbita] and 
arninopyrine (Bouth and Gillette, 196?.; Kato and Tak2yanaghi, 196 6). 
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but do not significantly altc>r the hydroxylation of zoxaz.olamine (Gillclte, 
196 3; Kato and Takayanghi, 1966). 3 ..:Methylcholanthrene increases 
the metabolism of zoxazolamine, but not aminopyrine or hexobarbital 
(Conney Eal. , 1960 -; Kato and Takayanghi, 1966). 
Methylchloroform significantly increased the levels of NADPH-
cytochrorne £ reductase and the content of CO ·-binding pigment (P-450) 
and did not change the spectral properties of the hem.oprotein (P- 45 0) 
when corn.pared to controls. Treatment of rats with phenobarbital 
significantly increases the activity of the liver microsomal NADPH-
cytochrome £ reductase (Jick and Shuster , 1960; Ernster and Orr enius, 
1965) and the content of CO-binding pigment (Kuntzman~ al., 1968) 
without changing the spectral properties of this pigment. Kato and 
Takayanaghi (1966) and Von Der Deeken and Hultin (1960) have 
cle1nonstrate<l that lreatment with 3-methylcholanthrene had no 
effect on NADPH-cytochrorne £ reductase activily while Alvares et al. 
(1967) and KuntzmanE al. (1968) have shown increases in the content 
of CO-binding pigrnent, but with different speclral properlies when 
comp a red lo controls . 
Inhibitor s of protein synthesis have been demonstrated to 
block the increase in hepatic drug mctabolisrn by known inducers. 
Pretreatment of animals wilh actinomycin D and cyclohcximide 
prevented the induction of significant decreases in hexobarbital 
37 
sleeping tirne by methylchloroform. The increase in the metabolis1n 
of aminopyrine was also blocked by cyclohexirnide pretreatment. 
These data support the hypothesis that the increase in drug-
metabolizing enzymes of anin1als exposed to methylchloroform 
rep re sen ts an induction of mo re enzyme protein . 
VI. SUMMARY AND CONCLUSIONS 
Rats were exposed for 24 hours to an atmospheric concentration 
of about 2500 PPM methylchloroform and in ~~ro and in vivo parameters 
of drug metabolism were measured 24 hours after the termination of 
exposure . 
( I ) Methylchloroform content was 10 - fold greater in the liver 
than the blood of exposed rats sacrificed immediate ly upon re!Tioval 
from the chamber. These findings suggest that methylchloroform acts 
systemically . 
(2) Hexobarbital and zoxazolamine sleeping tin1e s we re 
significantly decreased by exposure to methylchloroform vapor . 
(3) In vit!::_<2_ metabolism of hexobarbital, zoxazolamine, arnjno-
pyrine, NADPH-cytochrome £ reductase, and content of CO-binding 
pigment '-''ere significantly increased in animals exposed to methyl-
chlorofonn . 
(4) Actinomycin D and cycloheximide blocked the rnethyl-
chloroforn1 induced clccrC;c..se in hexobarbital sl e eping ti1ne . Cydo-
he x in1ide blocked the methylchlo rofo rm in due ed inc n:~ase in dernethylrt -
tion of aminopyrine. These data suggest that the increase in tbe drug -
metabolizing enzyrncs of the anin1a l s exposed to n1ethylchlorofon11 
was mediated through the synthesis of protein . 
(5) The spectrum of eT'. z yn1cs inclucccl by rn e thy!chlorofo-cm 
39 
appears to be closely correlated with the spectrum of enzymes induced 
by phenobarbital. 
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